Skip to content

Safety and efficacy study of local citrate anticoagulation as a replacement fluid base source for continuous renal replacement therapy

Safety and efficacy study of local citrate anticoagulation as a replacement fluid base source for continuous renal replacement therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104512
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-06-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal failure

Interventions

Control group:Citric acid, displacement solution, and sodium bicarbonate are used independently according to traditional methods.
New Strategy Group:The ratio of waste liquid flow rate to citric acid flow rate is 9-10:1, and no sodium bicarbonate is used.

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Admitted to emergency ICU, age >=18 years old; 2. Application of topical citrate anticoagulation regimen for CRRT treatment; 3. Blood gas analysis before blood purification showed 18mmol/L<=HCO3-<=27mmol/L.

Exclusion criteria

Exclusion criteria: 1. Pregnant patients 2. Presence of severe metabolic acidosis prior to treatment, PH7.45 and (or) HCO3->27 3. There are other etiologies that significantly affect the acid-base balance disorder (severe carbon dioxide retention disease, PCO2>80mmHg 4. Persistent shock that cannot be corrected by applying large doses of hemorrhoidal active drugs, norepinephrine pumping > 1ug/kg·min, dopamine >10ug/kg·min, MAP 10mmol/L 5. Severe fluid loss, such as gastric juice, intestinal juice, and third space fluid loss of more than 2L within 24 hours 6. The duration of CRRT treatment is less than 12 hours 7. Patient or family members are unable to understand the conditions and objectives of this study

Design outcomes

Primary

MeasureTime frame
Incidence of metabolic acid-base imbalance disorder;

Secondary

MeasureTime frame
Complete biochemical analysis;Electrolyte;Blood Gas Analysis;Filter lifespan;Sodium bicarbonate usage;The compliance rate of free calcium ions before and after the filter;The incidence of adverse bleeding events;The incidence of citric acid accumulation;

Countries

China

Contacts

Public ContactDingyu Tan

Northern Jiangsu People's Hospital

32494845@qq.com+86 180 5106 1672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026